WSGR logoWSGR logo
Ty Kayam
Of Counsel
Regulatory
Seattle

D206-883-2607

Download vCard
Open PDF

Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati. She advises companies and investors on regulatory strategy for health technology products, especially where legal risk depends on product architecture, data use, and clinical context. Her practice focuses on health AI, digital health, health data infrastructure, connected and wearable devices, and medical robotics.

Ty advises on product development, launch, investor diligence, and transactions where regulatory strategy drives business outcomes, including how claims, evidence, data flows, and regulatory pathways are structured for review in the United States and internationally. Her practice draws on experience at the FDA, Microsoft, and a national health information network, combining regulatory insight, technical fluency, and a systems-level understanding of how health technologies are built and scaled.

Ty was the first attorney in the FDA’s Digital Health Center of Excellence, where she worked on the agency’s approach to emerging health technologies, including lifecycle oversight, evidentiary expectations, predetermined change control plans, and pre- and post-market issues. She also worked on U.S. and international regulatory alignment and advised on cross-jurisdictional matters.

Previously, Ty was a senior attorney at Microsoft, advising on the development and launch of health AI and digital health products, including early generative AI applications in healthcare. She also helped build Microsoft’s health regulatory and policy strategy across global markets, including work on compliance frameworks for AI-enabled health products under emerging EU regulations. Before Microsoft, Ty was an attorney at a national health information network, where she worked on the infrastructure that determines whether health technology can connect, scale, and exchange data in practice. This included interoperability, information blocking, EHR connectivity, APIs, and clinical data exchange.

Ty has taught health technology law as an adjunct professor at Seattle University School of Law and has guest lectured at law schools across the United States and Canada. She is fluent in Telugu.

Experience

Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati. She advises companies and investors on regulatory strategy for health technology products, especially where legal risk depends on product architecture, data use, and clinical context. Her practice focuses on health AI, digital health, health data infrastructure, connected and wearable devices, and medical robotics.

Ty advises on product development, launch, investor diligence, and transactions where regulatory strategy drives business outcomes, including how claims, evidence, data flows, and regulatory pathways are structured for review in the United States and internationally. Her practice draws on experience at the FDA, Microsoft, and a national health information network, combining regulatory insight, technical fluency, and a systems-level understanding of how health technologies are built and scaled.

Ty was the first attorney in the FDA’s Digital Health Center of Excellence, where she worked on the agency’s approach to emerging health technologies, including lifecycle oversight, evidentiary expectations, predetermined change control plans, and pre- and post-market issues. She also worked on U.S. and international regulatory alignment and advised on cross-jurisdictional matters.

Previously, Ty was a senior attorney at Microsoft, advising on the development and launch of health AI and digital health products, including early generative AI applications in healthcare. She also helped build Microsoft’s health regulatory and policy strategy across global markets, including work on compliance frameworks for AI-enabled health products under emerging EU regulations. Before Microsoft, Ty was an attorney at a national health information network, where she worked on the infrastructure that determines whether health technology can connect, scale, and exchange data in practice. This included interoperability, information blocking, EHR connectivity, APIs, and clinical data exchange.

Ty has taught health technology law as an adjunct professor at Seattle University School of Law and has guest lectured at law schools across the United States and Canada. She is fluent in Telugu.

Focus Areas
WSGR logo
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.